| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.9M | +111.2% |
| Cost of Revenue | $14.9M | +129.0% |
| Gross Profit | $12.0M | +92.7% |
| R&D Expense | $0 | — |
| SG&A Expense | $11.2M | +280.2% |
| Operating Income | -$803K | -150.9% |
| Pre-tax Income | $69K | -95.6% |
| Net Income | $80K | -94.9% |
| EPS (Basic) | $0.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.8M | -20.9% |
| Accounts Receivable | $25K | -97.6% |
| Current Assets | $35.6M | -13.1% |
| Total Assets | $41.8M | -12.0% |
| Current Liabilities | $26.5M | -20.9% |
| Total Liabilities | $27.4M | -20.6% |
| Stockholders' Equity | $14.4M | +10.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | -134.5% |
| Investing Cash Flow | $445K | -61.8% |
| Financing Cash Flow | $256K | -97.1% |
| — |
| EPS (Diluted) | $0.00 | — |